OYV
- Product code
- OYV
- Device name
- Inherited Nucleotide Repeat Disorder Dna Test
- Device class
- Class 2
- 21 CFR
- 21 CFR 866.5970
- Medical specialty
- Immunology
- Marketing pathway
- 510(K)
- 510(k) clearances (all years, FDA)
- 1 (all years; only the last 3 years are listed here)
FDA classification definition
An inherited nucleotide repeat disorder DNA test is a prescription in vitro diagnostic test that is intended to detect and identify the number of nucleotide repeats in a gene using genomic DNA isolated from post-natal patient specimens. It is solely intended as an aid for carrier testing and as an aid for the diagnosis of inherited nucleotide repeat-associated disorders. Assay results are solely intended to be used in conjunction with other clinical and diagnostic findings. These tests do not include those indicated for use for fetal diagnostic testing or newborn screening.
Official FDA classification page: OYV
Classification and pathway per current FDA publications. Data from openFDA (CC0).